Analyst Price Target is $0.85
▲ +165.63% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Goodness Growth in the last 3 months. The average price target is $0.85, with a high forecast of $0.85 and a low forecast of $0.85. The average price target represents a 165.63% upside from the last price of $0.32.
Current Consensus is
The current consensus among 0 contributing investment analysts is to n/a stock in Goodness Growth. This rating has held steady since September 2021, when it changed from a Buy consensus rating.
Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.